Sort   by:  
 Page size 
UnknownSpatial Clustering of Receptors and Signaling Molecules Regulates NK Cell Response to Peptide Repertoire Changes.
Not available
S-EPMC6460049 | biostudies-literature
UnknownSynergistic inhibition of natural killer cells by the nonsignaling molecule CD94.
Not available
S-EPMC3801078 | biostudies-literature
UnknownPeptide selectivity discriminates NK cells from KIR2DL2- and KIR2DL3-positive individuals.
Not available
S-EPMC4324016 | biostudies-literature
UnknownIdentifying the immune interactions underlying HLA class I disease associations.
Not available
S-EPMC7253178 | biostudies-literature
UnknownThe interaction of genetic determinants in the outcome of HCV infection: evidence for discrete immunological pathways.
Not available
S-EPMC4858811 | biostudies-literature
UnknownGenetic variation in the interleukin-28B gene is associated with spontaneous clearance and progression of hepatitis C virus in Moroccan patients.
Not available
S-EPMC3554614 | biostudies-literature
UnknownSynergism of tapasin and human leukocyte antigens in resolving hepatitis C virus infection.
Not available
S-EPMC3759612 | biostudies-literature
UnknownXPO1 inhibition sensitises CLL cells to NK cell mediated cytotoxicity and overcomes HLA-E expression.
Not available
S-EPMC10539165 | biostudies-literature
UnknownDistinct virologic trajectories in chronic hepatitis B identify heterogeneity in response to nucleos(t)ide analogue therapy.
Not available
S-EPMC11664071 | biostudies-literature
UnknownHepatitis B Virus (HBV) Treatment Eligibility in the UK: Retrospective Longitudinal Cohort Data to Explore the Impact of Changes in Clinical Guidelines.
Not available
S-EPMC12548009 | biostudies-literature
Sort   by:  
 Page size